1. Luo, Na, Zhang, KeJing, Li, Xin, Hu, Yu, Guo, Lei. 2024. Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer. In Journal of advanced research, 69, 313-327. doi:10.1016/j.jare.2024.04.009. https://pubmed.ncbi.nlm.nih.gov/38615741/
2. Jin, Shouheng, He, Xing, Ma, Ling, Zhao, Jincun, Cui, Jun. 2022. Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy. In Nature communications, 13, 5204. doi:10.1038/s41467-022-32957-y. https://pubmed.ncbi.nlm.nih.gov/36057605/
3. Liu, Qiang, Zhou, Baoyong, Liao, Rui, Zhou, Xiong, Yan, Xiong. 2020. PIAS4, upregulated in hepatocellular carcinoma, promotes tumorigenicity and metastasis. In Journal of cellular biochemistry, 121, 3372-3381. doi:10.1002/jcb.29610. https://pubmed.ncbi.nlm.nih.gov/31943317/
4. Chien, W, Lee, K L, Ding, L W, Said, J W, Koeffler, H P. 2013. PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells. In British journal of cancer, 109, 1795-804. doi:10.1038/bjc.2013.531. https://pubmed.ncbi.nlm.nih.gov/24002598/
5. Kumar, Ramesh, Cheok, Chit Fang. 2017. Dynamics of RIF1 SUMOylation is regulated by PIAS4 in the maintenance of Genomic Stability. In Scientific reports, 7, 17367. doi:10.1038/s41598-017-16934-w. https://pubmed.ncbi.nlm.nih.gov/29234018/
6. Sun, Lina, Fan, Zhiwen, Chen, Junliang, Xia, Jun, Xu, Yong. . Protein inhibitor of activated STAT 4 (PIAS4) regulates pro-inflammatory transcription in hepatocytes by repressing SIRT1. In Oncotarget, 7, 42892-42903. doi:10.18632/oncotarget.9864. https://pubmed.ncbi.nlm.nih.gov/27285989/
7. Xu, Huihui, Fan, Zhiwen, Tian, Wenfang, Xu, Yong. 2016. Protein inhibitor of activated STAT 4 (PIAS4) regulates liver fibrosis through modulating SMAD3 activity. In Journal of biomedical research, 30, 496-501. doi:10.7555/JBR.30.20160049. https://pubmed.ncbi.nlm.nih.gov/27924068/
智鼠故事 
